Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 0M2XT000YC

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Endosialin inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Melanoma 2 D008545 ClinicalTrials
Sarcoma 2 D012509 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2364659
FDA SRS 0M2XT000YC